Collins Stewart Raises Price Target on BioMarin Pharmaceutical (BMRN) Following Solid Q1 Results and Q2 Guidance
Go back to Collins Stewart Raises Price Target on BioMarin Pharmaceutical (BMRN) Following Solid Q1 Results and Q2 Guidance| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 66.70 -0.98 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.68 | 52 Week High | $108.96 | |||
| Open | $67.55 | 52 Week Low | $62.12 | |||
| Day High | $68.34 | P/E | N/A | |||
| Day Low | $66.52 | EPS | $-1.27 | |||
| Volume | 1,593,613 | |||||
